Compound ID | 926
Class: Aminoacyl-tRNA synthetase inhibitor (phenylanalyl-tRNA synthetase [PheRS] inhibitor)
Spectrum of activity: | Gram-negative |
Institute where first reported: | Cubist Pharmaceuticals (Merck & Co, USA) |
Year first mentioned: | 2001 |
Highest developmental phase: | Preclinical |
Chemical structure(s): | |||||||||||
|
|
External links: | |
Citation: | https://www.drugfuture.com/synth/syndata.aspx?ID=288178 |